pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·3h ago·1 min read
save

AAFP chief urges Congress to add oversight to CDC vaccine advisory panel

Nov 5, 2026·read at Endpoints ↗RegulatoryNeutral

Shawn Martin, CEO of the American Academy of Family Physicians, said the CDC’s Advisory Committee on Immunization Practices (ACIP) has faced more than a year of turmoil.

He is urging Congress to establish clearer guardrails that would give external members more authority and protect the panel from political pressure.

Martin’s call comes as the AAFP seeks to ensure that vaccine recommendations remain scientifically driven and transparent for physicians and patients.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “Head of family physician group seeks ACIP 'guardrails'”

read at Endpoints ↗
86 words · retrieved 2h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Sionna Therapeutics, Inc.
topics
Vaccine2AdComVaccines

related stories

  • Jul 31Moderna maintains 10% growth target despite Phase 3 norovirus missBioSpace
  • Jul 20HHS vaccine committee quietly gets new charterSTAT
  • Jul 8Sanofi offers to end disparaging claims against CSL flu shot in EuropeEndpoints
  • Jul 2Opinion: CDC leadership continues to try to manufacture a scientific debate on vaccines where none existsSTAT
  • Jun 18STAT+: FDA advisory panel endorses Moderna mRNA flu vaccine that was subject of controversySTAT